Globus Medical, Inc. (GMED) — Financial statements
Income statement, balance sheet, and cash flow for Globus Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,939↑16.7% | 2,519↑60.6% | 1,568↑53.3% | 1,023↑6.8% | 958 | |
| Cost of Revenue | 958↓7.5% | 1,035↑88.9% | 548↑107.9% | 264↑10.2% | 239 | |
| Gross Profit | 1,981↑33.5% | 1,484↑45.4% | 1,020↑34.4% | 759↑5.6% | 719 | |
| Operating Expenses | ||||||
| R&D Expenses | 185↑13.0% | 164↑32.0% | 124↑69.8% | 73↓25.0% | 97 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 1,316↑34.2% | 981↑52.5% | 643↑48.9% | 432↑5.9% | 408 | |
| Other Expenses | 0.00↓100.0% | 173↑44.5% | 120↑359.9% | 26↓37.2% | 41 | |
| Operating Expenses | 1,501↑13.9% | 1,318↑48.6% | 887↑67.0% | 531↓2.9% | 547 | |
| Total Costs & Expenses | 2,459↑4.5% | 2,353↑64.0% | 1,435↑80.6% | 795↑1.1% | 786 | |
| Operating Results | ||||||
| Operating Income | 480↑189.1% | 166↑24.7% | 133↓41.6% | 228↑32.6% | 172 | |
| Depreciation & Amortization | 120↓52.8% | 254↑75.5% | 145↑112.1% | 68↓2.3% | 70 | |
| EBITDA | 730↑54.1% | 474↑36.7% | 347↑13.8% | 305↑15.0% | 265 | |
| EBIT | 610↑177.6% | 220↑8.8% | 202↓14.6% | 236↑21.2% | 195 | |
| Interest & Other Income | ||||||
| Net Interest Income | 7↑270.5% | -4↓120.8% | 20↑41.4% | 14↑53.1% | 9 | |
| Interest Income | 7 | 0.00↓100.0% | 20↑41.4% | 14↑53.1% | 9 | |
| Interest Expense | 0.00↓100.0% | 4 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -130↓142.2% | -54↑21.8% | -69↓727.8% | -8↑63.8% | -23 | |
| Other Income / Expenses | 130↑387.4% | -45↓240.4% | 32↑114.0% | 15↑78.2% | 8 | |
| Income Before Tax | 610↑405.2% | 121↓27.0% | 165↓31.9% | 243↑34.7% | 180 | |
| Income Tax Expense | 72↑305.9% | 18↓58.3% | 43↓19.5% | 53↑69.3% | 31 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 538↑422.3% | 103↓16.2% | 123↓35.4% | 190↑27.5% | 149 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 538↑422.3% | 103↓16.2% | 123↓35.4% | 190↑27.5% | 149 | |
| Bottom-Line Net Income | 538↑422.3% | 103↓16.2% | 123↓35.4% | 190↑27.5% | 149 | |
| EPS (Basic) | 3.98↑423.7% | 0.76↓30.3% | 1.09↓42.3% | 1.89↑27.7% | 1.48 | |
| EPS (Diluted) | 3.92↑422.7% | 0.75↓29.9% | 1.07↓42.2% | 1.85↑28.5% | 1.44 | |
| Weighted Average Shares | 135↓0.4% | 136↑20.0% | 113↑12.6% | 100↓0.3% | 101 | |
| Weighted Average Diluted Shares | 137↓0.5% | 138↑20.3% | 115↑11.7% | 103↓0.9% | 104 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.